Clinical trial Recruiting at 1 site Observational Ages 2 and up

National map of cutaneous lymphomas in Italy

Official title: National Epidemiology of Cutaneous Lymphomas

Run by IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT07463989 · Data updated 2026-11-12

This project will try to map how common cutaneous lymphomas are across Italy and see if certain places or environmental exposures are linked to more cases in people with cutaneous lymphoma.

Quick facts

Study typeObservational
Ages2 Years and up
SexAll
Enrollment1000 (estimated)
SponsorIRCCS Azienda Ospedaliero-Universitaria di Bologna
Academic / other
Locations1 site (Bologna, Bologna)
StatusRecruiting
StartedMay 13, 2025
Main results expectedMay 13, 2028
Study endsMay 13, 2030
Registry record updatedMarch 11, 2026
Trial IDNCT07463989 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are people aged over 2 years with a diagnosis of primary cutaneous lymphoma who can provide informed consent (or whose guardians can) and are seen at participating Italian dermatology centers.

Probably not a fit

People without primary cutaneous lymphoma (for example those with systemic lymphoma involving the skin) or those who cannot attend participating Italian sites are unlikely to benefit from this project.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a multicenter observational project combining a retrospective review (patients diagnosed 2018–2022) with a prospective three‑year enrollment phase to build a national registry of primary cutaneous lymphomas in Italy. About 1,000 patients from participating dermatology departments will be included, with the IRCCS Azienda Ospedaliero-Universitaria di Bologna coordinating the effort. The study will record clinical, histopathologic, immunophenotypic, and basic molecular data to describe incidence and prevalence and to look for geographic clustering. Investigators will also explore associations with environmental pollutant exposure and coexisting health conditions.

Why it matters

Potential benefit: If successful, it could reveal geographic hotspots and environmental links that help guide earlier diagnosis, targeted monitoring, and public health measures for people with cutaneous lymphoma.

How similar studies have gone: International registry and epidemiology studies have generated useful incidence data and suggested environmental patterns, but a comprehensive nationwide Italian registry is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients over 2 years of age
* Patients with cutaneous lymphoma
* Obtaining informed consent

Exclusion Criteria:

* NA

Where it's running

  • IRCSS Azienda Ospedaliero-Universitaria di Bologna
    Bologna, Bologna, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.